Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024

SELL
$272.08 - $333.53 $2.78 Million - $3.4 Million
-10,200 Reduced 3.24%
304,900 $102 Million
Q4 2023

Feb 14, 2024

BUY
$221.81 - $275.85 $8.69 Million - $10.8 Million
39,200 Added 14.21%
315,100 $85.3 Million
Q3 2023

Nov 14, 2023

BUY
$245.98 - $298.35 $13 Million - $15.8 Million
52,900 Added 23.72%
275,900 $67.9 Million
Q2 2023

Aug 14, 2023

SELL
$264.09 - $303.48 $27.9 Million - $32.1 Million
-105,800 Reduced 32.18%
223,000 $67.7 Million
Q1 2023

May 15, 2023

SELL
$243.35 - $263.81 $5.48 Million - $5.94 Million
-22,500 Reduced 6.4%
328,800 $86.7 Million
Q4 2022

Feb 14, 2023

SELL
$193.26 - $244.85 $19 Million - $24 Million
-98,100 Reduced 21.83%
351,300 $84.3 Million
Q3 2022

Nov 14, 2022

BUY
$165.99 - $222.36 $27.8 Million - $37.2 Million
167,200 Added 59.25%
449,400 $82.6 Million

Others Institutions Holding HCA

About HCA Healthcare, Inc.


  • Ticker HCA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 287,024,992
  • Market Cap $92.2B
  • Description
  • HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surger...
More about HCA
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.